imugene.com imugene.com

imugene.com

immuno-oncology focused biopharmaceutical company - Imugene

Board of Directors and Management. Board of Directors and Management. Imugene Ltd is building a pipeline of B-cell peptide cancer vaccines. Imugene (ASX; IMU) is an immuno-oncology focused biopharmaceutical company developing HER-2 gastric and breast cancer immunotherapies. Our mission is to build a pipeline of B-cell peptide cancer vaccines. View Imugene CEO Leslie Chong presenting at the 10th Annual Biotech Showcase, San Francisco Jan 18 ( click here. Our lead product is HER-Vaxx. HER-Vaxx has successf...

http://www.imugene.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IMUGENE.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.3 out of 5 with 9 reviews
5 star
1
4 star
5
3 star
1
2 star
0
1 star
2

Hey there! Start your review of imugene.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.8 seconds

CONTACTS AT IMUGENE.COM

Imugene Limited

Graham Dowland

c/- B●●●●●yware

PO ●●● 31

Wes●●●rth , WA, 6872

au

61.8●●●●4990
an●●●●●@bizanyware.com.au

View this contact

Imugene Limited

Annette Batten

c/- B●●●●●yware

PO ●●● 31

Wes●●●rth , WA, 6872

au

61.8●●●●4990
an●●●●●@bizanyware.com.au

View this contact

Imugene Limited

Annette Batten

c/- B●●●●●yware

PO ●●● 31

Wes●●●rth , WA, 6872

au

61.8●●●●4990
an●●●●●@bizanyware.com.au

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2002 July 30
UPDATED
2012 October 20
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 22

    YEARS

  • 10

    MONTHS

  • 6

    DAYS

NAME SERVERS

1
ns1.yourdnshost.net
2
ns2.yourdnshost.net
3
ns3.yourdnshost.net

REGISTRAR

NETREGISTRY PTY. LTD.

NETREGISTRY PTY. LTD.

WHOIS : whois.netregistry.net

REFERRED : http://www.netregistry.com.au

CONTENT

SCORE

6.2

PAGE TITLE
immuno-oncology focused biopharmaceutical company - Imugene | imugene.com Reviews
<META>
DESCRIPTION
Board of Directors and Management. Board of Directors and Management. Imugene Ltd is building a pipeline of B-cell peptide cancer vaccines. Imugene (ASX; IMU) is an immuno-oncology focused biopharmaceutical company developing HER-2 gastric and breast cancer immunotherapies. Our mission is to build a pipeline of B-cell peptide cancer vaccines. View Imugene CEO Leslie Chong presenting at the 10th Annual Biotech Showcase, San Francisco Jan 18 ( click here. Our lead product is HER-Vaxx. HER-Vaxx has successf...
<META>
KEYWORDS
1 about us
2 scientific advisory board
3 corporate governance
4 her vaxx
5 clinical trials
6 intellectual property
7 publications
8 arginine modulators
9 mimotopes
10 business development
CONTENT
Page content here
KEYWORDS ON
PAGE
about us,scientific advisory board,corporate governance,her vaxx,clinical trials,intellectual property,publications,arginine modulators,mimotopes,business development,investor center,analyst coverage,annual reports,asx announcements,investor presentations
SERVER
Apache
POWERED BY
PHP/5.3.29
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

immuno-oncology focused biopharmaceutical company - Imugene | imugene.com Reviews

https://imugene.com

Board of Directors and Management. Board of Directors and Management. Imugene Ltd is building a pipeline of B-cell peptide cancer vaccines. Imugene (ASX; IMU) is an immuno-oncology focused biopharmaceutical company developing HER-2 gastric and breast cancer immunotherapies. Our mission is to build a pipeline of B-cell peptide cancer vaccines. View Imugene CEO Leslie Chong presenting at the 10th Annual Biotech Showcase, San Francisco Jan 18 ( click here. Our lead product is HER-Vaxx. HER-Vaxx has successf...

INTERNAL PAGES

imugene.com imugene.com
1

Analyst Coverage - Imugene

http://www.imugene.com/investor-center/analyst-coverage

Board of Directors and Management. Board of Directors and Management. In December 2013 we successfully acquired HER-Vaxx from Biolife Science. 6 June 2016 - Bioshares. 18 April 2016 - Redchip Research Report. 19 February 2016 - Edison Research Note. 25 January 2016 - Bioshares. 13 July 2015 - Edison Research Note (HER-Vaxx antibodies outperform Herceptin). 13 April 2015 - Edison Research Note. 27 November 2014 - Edison Research Note. View Charles Walker being interviewed by Proactive Investors.

2

Company - Imugene

http://www.imugene.com/company/scientific-advisory-board

Board of Directors and Management. Board of Directors and Management. HER-Vaxx has successfully completed a Phase I study in breast cancer and the next stage of development will be a Phase II study in gastric cancer. Professor Zielinski is a member of the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR) and the European Society for Medical Oncology (ESMO). He has published more than 420 original research papers and reviews in peer reviewed journals.

3

Mimotopes - Imugene

http://www.imugene.com/products/mimotopes

Board of Directors and Management. Board of Directors and Management. HER-2 cancer immunotherapy that stimulates a polyclonal antibody response to HER-2. Using Phage display, it has been possible to screen libraries of peptides using monoclonal antibodies for candidates that mimic the effect of target epitopes. Imugene has acquired an option to continue this research and development of Mimotope Vaccines with the Company’s scientific team in Austria. The mimotopes targeting Trastuzamab and Her-2 are prote...

4

Intellectual Property - Imugene

http://www.imugene.com/products/intellectual-property

Board of Directors and Management. Board of Directors and Management. HER-2 cancer immunotherapy that stimulates a polyclonal antibody response to HER-2. Imugene acquired the IP for the HER-Vaxx immunotherapy through the acquisition of Biolife Science Qld Limited in late 2013. This included the global rights to four patents. WO02068474, Vaccine against Cancer Diseases that are associated with the HER-2/neu Oncogene, protects specific HER-2 B-cell epitopes. WO2006/069719, Lyophilisation of Virosomes, gran...

5

Corporate Governance - Imugene

http://www.imugene.com/corporate-governance

Board of Directors and Management. Board of Directors and Management. HER-Vaxx is a proprietary HER-2 cancer immunotherapy that targets the same well established cancer biomarker as Herceptin. Audit and Risk Committee Charter. Continuous Disclosure Policy and Communications Strategy. Remuneration and Nomination Committee Charter. Imugene Receives Approval from Thailand to Start Gastric Cancer Study. Imugene Receives IRB approval from the Taipei Veterans General Hospital. Appendix 4C - Quaterly.

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

SOCIAL ENGAGEMENT



OTHER SITES

imuge.com imuge.com

imuge.com - This website is for sale! - imuge Resources and Information.

The domain imuge.com. May be for sale by its owner! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

imugem.com imugem.com

Coming Soon

Our website is coming soon.

imugem.deviantart.com imugem.deviantart.com

imugem (megumi) - DeviantArt

Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) " class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 9 Years. This deviant's full pageview. Last Visit: 161 weeks ago. This is the place where you can personalize your profile! By moving, adding and personalizing widgets. Why," you ask? God, fine art...

imugen.com imugen.com

Home - Imugen

Imugen combines with Oxford Immunotec. Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions. The Company’s first product is the T-SPOT. Test, which is used to test for tuberculosis infection. The T-SPOT. 315 Norwood Park South Norwood MA 02062. 781) 255-0770 800-246-8436 Fax (781) 255-9923.

imugen.skyrock.com imugen.skyrock.com

Music Blog of imugen - imugen - Skyrock.com

La Musique . dans la peau! MUGEN : [mugèn] n.m :. 1 En japonnais mugen signifie infinie,sans limite. 2 Mugen est également le personnage principal de Samurai Champloo que vous pouvez voir ci-dessus. 3 Honda CIvic MUGEN, voiture puissante du grand constructeur japonnais Honda. 4 Moteur de jeu pour les jeux de combat 2D. 03/07/2007 at 11:39 AM. 15/07/2008 at 9:15 PM. Subscribe to my blog! Add to my blog. Add to my blog. Add to my blog. Add to my blog. Once Upon a Time in the West. Add to my blog. Listen to...

imugene.com imugene.com

immuno-oncology focused biopharmaceutical company - Imugene

Board of Directors and Management. Board of Directors and Management. Imugene Ltd is building a pipeline of B-cell peptide cancer vaccines. Imugene (ASX; IMU) is an immuno-oncology focused biopharmaceutical company developing HER-2 gastric and breast cancer immunotherapies. Our mission is to build a pipeline of B-cell peptide cancer vaccines. View Imugene CEO Leslie Chong presenting at the 10th Annual Biotech Showcase, San Francisco Jan 18 ( click here. Our lead product is HER-Vaxx. HER-Vaxx has successf...

imugensya.blogspot.com imugensya.blogspot.com

いわき明星大学現代社会学科のブログ

いわき明星大学現代社会学科のBlogです。イベントの紹介やリポートなど、いろいろな情報を発信していきたいと思います。 12288;いわき明星大学高木研究室では、2017年7月に会津若松市、郡山市、いわき市の住民を対象に質問紙調査を実施いたしました。調査の協力いただいた皆様、大変ありがとうございました。大変遅くなりましたが、調査の結果を報告します。 12288;現在、プレスリリース用の文章をまとめているところですが、まずは調査票の各設問に対する回答結果をお示しいたします(2/18)。 このたび、いわき明星大学高木研究室では、会津若松市、郡山市、いわき市の住民を対象に質問紙調査を実施することになりました。これは福島にお住まいの方々の原発事故からの復興に対する意識と行動を明らかにする目的で実施するもので、文部科学省の科学研究費にもとづく調査研究です。 各市の選挙管理委員会の協力を得て個人情報を得ていますが、それは調査票、お礼状、調査結果の報告書の発送以外には使用いたしません。 なにとぞご理解いただければと思います。 9675; プレスリリース・図表. アンケートは楢葉町に住民票のある16歳から49歳までのすべ...

imugent.com imugent.com

サテライトサイトプロダクト

imuggs.com imuggs.com

Web hosting, domain name registration and web services by 1&1 Internet

THIS DOMAIN NAME HAS JUST BEEN REGISTERED FOR ONE OF OUR CUSTOMERS! Do you need affordable web hosting or a domain name? 1&1 Internet is trusted by millions. Find out why. Offers a one-stop shop for all your domain name and web hosting needs so you can maximize your full web potential — without barriers, and without fear. Smart webmasters choose 1&1 Internet for domain name registration and hosting solutions. All-Inclusive Hosting Plans with NO Hidden Charges. 24/7 Phone and E-mail Support.

imuggy.com imuggy.com

www.imuggy.com

This page requires that your browser supports frames. You can access the page without frames with this link.